Research program
Major themes
- Small molecules, immunomodulators and cell therapies
- Genomics-based diagnosis and RNA-based therapies for emerging infections
- Vaccine development, production and evaluation
Priorities
- Establish sustainable linkages with global surveillance groups, and develop strategies for early detection.
- Optimize the use of biobanking data (samples, pathogens, databases).
- Promote the development, testing and manufacturing of novel diagnostic methods for pathogen detection and host response.
- Accelerate the use of RNA-based approaches and therapies against pandemic pathogens.
- Develop immune-based approaches, such as vaccines, biologics and cell therapies against pandemic pathogens; and RNA-based approaches, virology research, vaccines, therapeutics, biologics, cell therapies, AI, preclinical studies and digital platform for conducting virtual clinical trials emerging pathogens, including identification (Dx), preventive (e.g., vaccines) and therapeutic (e.g., antiviral, anti-inflammatory and supportive therapies) solutions.
- Invest in new strategies to develop and produce novel therapeutics.
- Provide the capacity for state-of-the-art in vitro, in vivo and ex vivo preclinical models of pandemic pathogens.
- Create platforms for rapid clinical trials to respond to an emerging threat.
- Stimulate the bioprocessing and manufacturing of small molecules, nucleic acids, recombinant proteins, viral vectors and human cells to provide a complete armamentarium against pandemic pathogens.
- Instill a tradition of impact by facilitating entrepreneurship and dialogue with decision and policy makers, and the general public.
- Strengthen the workforce capacity and new talents in pandemic preparedness and biomanufacturing.
- Facilitate collaboration with governmental organizations and policy makers, commercialization of discoveries, strategic partnerships, and entrepreneurship.
- Ensure expertise for communication with the public to ensure adoption.
- Support the biomanufacturing ecosystem following current good manufacturing practices.
Types of proposals
Components:
- Research: High-risk, partnered, applied research initiatives in biomanufacturing and life sciences with high potential to accelerate the translation of discoveries into product/service development
- Talent: Skills and training for Canada’s biomanufacturing industry
- Infrastructure: Enable bioscience research in Canada
Note: Infrastructure proposals supporting only talent development will not be accepted.
This content has been updated on 16 May 2023 at 16 h 00 min.